🇱🇰💊 Govt. Approves Rs. 2.5 Bn Medical Supplies Procurement

• The Cabinet has sanctioned key medical procurements worth approximately Rs. 2.5 billion to ensure a steady supply of essential medicines and equipment across State hospitals. • Key Procurements Approved: • Epoetin Syringes: 2.25 million pre-filled syringes (for chronic kidney disease) from Reliance Life Sciences Ltd. (India). Total value: US$ 1.989 million. • Infliximab Vials: 24,000 vials (a biological drug for Crohn’s disease/arthritis) from Celltrion Inc. (South Korea) for US$ 3 million. • Human Growth Hormone (Somatropin): 448,000 IU (for growth deficiencies) via A. Baur & Co. Ltd., for Rs. 860.5 million. • Colistimethate Sodium: 218,000 vials of the antibiotic (for severe bacterial infections) via Ceyoka Ltd., for Rs. 32.48 million. • Soft Cloth Liner Tape: 500,000 rolls (for bandaging) approved for George Steuart Health Ltd. for Rs. 270.56 million (excluding VAT). • All procurements followed international competitive bidding and were evaluated by the High-Level Standing Procurement Committee and Procurement Appeal Board, emphasizing transparency in strengthening the public health supply chain.